Submit. Biotech founders submit promising research proposals aiming to reach inflection points in the drug development lifecycle.
Finance. The Vibe Bio expert diligence committee will evaluate all submissions during any stage of development to identify projects for funding opportunities.
Community. Patients, biotech entrepreneurs, and investors come together to advance the research of high-potential medicines.
Support. Vibe Bio assists selected projects in the identification of key studies and financing strategies required to achieve the company's next capital raise.
For too many patients with overlooked diseases, the time it would take to develop a cure is longer than the time they have left.
For the first time, we're developing and scaling treatments for overlooked and under-funded diseases— and giving biotechs unprecedented access to financing.
To do that, we partner with biotech companies who are working on treatments that otherwise would languish on a shelf. We leverage innovative sources of financing so that no one has to forge the path to a cure alone.
Vibe Bio partners with an expansive ecosystem of industry thought leaders reshaping the biotech landscape across research and development, clinical trials and funding. Our mission: every cure for every community requires a diverse set of perspectives, expertise and passion.
Interested in learning more and joining the cause? Send our team an email at email@example.com or connect with us on social!
Chelsea’s Hope is a foundation dedicated to finding a cure for Lafora disease, which causes seizures and cognitive and physical decline. Most patients pass away within 10 years of the onset of symptoms. Vibe Bio is partnering with Chelsea’s Hope to start new clinical trials and finally find a cure. Together, we have founded New Hope, a biotech company that will build on promising research into potential therapies for Lafora disease to finally get patients the treatment they need. Read more about Chelsea’s Hope.
Vibe Bio helps biotechs by funding & developing high-potential drug programs through value inflection points. Our core is a community of scientists, patients, and partners that help us identify and support these promising companies & treatments. Vibe Bio is funding and advancing projects that currently are not getting the funding and attention they deserve.
Inflection Points in biotech are typically moments in time when a particular scientific, clinical, or business milestone has been reached that increases the company’s valuation, thus leading to the company’s next round of investment.
Every patient with a life-altering disease should feel a part of a community with the power to pursue their cure. But too many patients with overlooked diseases are too often abandoned because the treatments they need are considered too costly and risky. Oftentimes, biotech companies need money to generate data, but investors want to see more data to feel comfortable investing, thus creating an unbreakable cycle.
The biggest obstacle to treating patients with overlooked diseases isn’t finding them - it’s funding them. Unlocking capital is a critical step in propelling biotechnology companies toward pivotal inflection points in their development journey. As biotechs work tirelessly to improve the lives of millions, access to sufficient funding is essential to fuel their groundbreaking research, drive innovation, and accelerate the translation of novel discoveries into real-world applications. By providing strategic financial resources, we not only support the growth of these cutting-edge companies but also contribute to the advancement of the entire biotech ecosystem.
Biotech companies can submit their proposals and work to our team. The Vibe expert diligence committee carefully reviews and vets all proposals that are submitted for review. Their assessments are synthesized and inform the feasibility and potential associated with proposed projects.
We are always eager to connect with patients, families, advocates, scientists, biopharma companies, and others who are as passionate as we are about financing treatments for overlooked diseases. Please contact us here to let us know that you’re interested in working together.
You can join the Vibe community by joining our Discord or partnering with us. If you’re interested in working together or want more information about our model, please fill out this form.
For patients and drug developers, there is no financial cost to support and participate in the Vibe Bio community.
Vibe Bio has access to capital via community activities and dedicated funds, in addition to external investors.
The drug development work is performed by experienced drug developers, scientists, contract partners (e.g. contract research organizations, contract manufacturing organizations), and medical establishments (e.g. for clinical trials).
1 in 10 Americans suffer from a rare disease. Vibe Bio is focused on rare diseases because of the urgent need for cures and because of the vibrant and motivated communities who are already organized in pursuing those cures. Vibe Bio is funding and advancing projects that currently are not getting the funding and attention they deserve.
When Vibe Bio founder Alok Tayi and his wife had their first child, she was born very sick and spent a long time suffering in the hospital. The biology behind her conditions is well understood, but there were no therapeutic options available to her. They felt frustrated and alone.
Through that experience, Alok connected with other families with sick children in the NICU and realized that the problem with drug development is not that we can’t find cures; it’s that we don’t have the funding to do it. That’s what motivated him to create Vibe Bio, which will give biotechs unprecedented access to unlock financing and a community to support them along the way.